Xbrane Biopharma announces product portfolio update with a new full strategic focus on biosimilars

Press release20180910 The board of directors of Xbrane Biopharma publ. "Xbrane" or the Company has decided to shift strategic focus in the Company's product pipeline to biosimilars. As Xbranes leading biosimilar Xlucane rani...